メタボロミクス：技術と世界市場

世界のメタボロミクスの市場規模は、2024年の164億米ドルから、予測期間中はCAGR 13.1%で推移し、2029年末には302億米ドルに達すると予測されています。

分離技術の部門は、2024年の83億米ドルから、CAGR 13.1％で推移し、2029年末までに154億米ドルに達すると予測されています。また、検出技術の部門は、2024年の80億米ドルから、CAGR 13.0%で推移し、2029年末には148億米ドルに達すると予測されています。

当レポートでは、世界のメタボロミクスの市場を調査し、市場概要、市場影響因子および市場機会の分析、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

• 市場見通し
• 調査範囲
• 市場概要

第2章 市場概要

• 概要
• メタボロミクスの概要
• 分離技術
• 検出技術
• 代謝物とその応用
• 研究開発と規制承認
• サプライチェーン分析

第3章 市場力学

• 市場力学
• 市場促進要因
• 市場抑制要因
• 市場機会
• 市場の課題

第4章 新興技術と開発

• 臨床試験分析
• 研究タイプ別
• ステータス別
• 性別
• 介入別
• 取得特許
• 特許分析

第5章 市場セグメンテーション分析

• セグメンテーションの内訳
• メタボロミクス市場：製品別
• 世界市場の分析・予測
• 分離技術
• 検出技術
• メタボロミクス市場：適応症別
• 世界市場の分析・予測
• 癌
• 心血管疾患
• 神経学的障害
• 先天性代謝異常
• その他
• メタボロミクス市場：用途別
• 世界市場の分析・予測
• バイオマーカーの発見
• 創薬
• 毒性試験
• ニュートリゲノミクス
• 機能ゲノミクス
• その他
• メタボロミクス市場：地域別
• 世界
• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 競合情報

• 企業シェア分析
• 戦略分析
• M&A
• ベンチャーキャピタル資金調達

第7章 付録

• 調査手法
• 略語
• 出典
• 企業プロファイル
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• BRUKER
• DANAHER CORP.
• MERCK KGAA
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.

List of Tables

• Summary Table : Global Market for Metabolomics Technologies, by Product, Through 2029
• Table 1 : Publications Referencing Metabolomics, 2021-2023
• Table 2 : Mass Spectrometry Products from Different Global Players
• Table 3 : Prices of Mass Spectrometry Products from Different Global Players
• Table 4 : Mass Spectrometry Steps to Metabolite Identification
• Table 5 : Various Metabolites and Their Functions and Applications
• Table 6 : Metabolomics Supply Chain
• Table 7 : Metabolomics Supply Chain Examples
• Table 8 : List of Bioinformatics Tools Used in Metabolomics
• Table 9 : List of Biomarkers Used in the Metabolomics and Applications
• Table 10 : Global Regulatory and Ethical Considerations for Metabolomics-Based Products
• Table 11 : Metabolomics Emerging Technologies
• Table 12 : Selected Clinical Trials Data for Metabolomics, 2021-2024
• Table 13 : Selected Granted Patents of Metabolomics, 2022 and 2023
• Table 14 : Global Market for Metabolomics Technologies, by Product, Through 2029
• Table 15 : Global Market for Separation Techniques in Metabolomics Technologies, by Region, Through 2029
• Table 16 : Global Market for Detection Techniques in Metabolomics Technologies, by Region, Through 2029
• Table 17 : Global Market for Metabolomics Technologies, by Disease Indication, Through 2029
• Table 18 : Global Market for Metabolomics Technologies for Cancer Indication, by Region, Through 2029
• Table 19 : Global Market for Metabolomics Technologies for Cardiovascular Disorders, by Region, Through 2029
• Table 20 : Global Market for Metabolomics Technologies for Neurological Disorders, by Region, Through 2029
• Table 21 : Global Market for Metabolomics Technology for Inborn Errors of Metabolism, by Region, Through 2029
• Table 22 : Global Market for Metabolomics Technologies for Other Diseases Indication, by Region, Through 2029
• Table 23 : Global Market for Metabolomics Technologies, by Application, Through 2029
• Table 24 : Global Market for Metabolomics Technologies in Biomarker Discovery, by Region, Through 2029
• Table 25 : Global Market for Metabolomics Technologies in Drug Discovery, by Region, Through 2029
• Table 26 : Global Market for Metabolomics Technologies in Toxicology Testing, by Region, Through 2029
• Table 27 : Global Market for Metabolomics Technologies in Nutrigenomics, by Region, Through 2029
• Table 28 : Global Market for Metabolomics Technologies in Functional Genomics, by Region, Through 2029
• Table 29 : Global Market for Metabolomics Technologies in Other Applications, by Region, Through 2029
• Table 30 : Global Market for Metabolomics Technologies, by Region, Through 2029
• Table 31 : North American Market for Metabolomics Technologies, by Country, Through 2029
• Table 32 : European Market for Metabolomics Technologies, by Country, Through 2029
• Table 33 : Asia-Pacific Market for Metabolomics Technologies, by Country, Through 2029
• Table 34 : Rest of the World Market for Metabolomics Technologies, Through 2029
• Table 35 : Merger and Acquisitions in the Global Market for Metabolomics Technologies, 2023
• Table 36 : Funded Projects for Metabolomics Technologies, 2021-2024
• Table 37 : Report Sources
• Table 38 : Major Acronyms Used in This Report
• Table 39 : Agilent Technologies Inc.: Company Snapshot
• Table 40 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
• Table 41 : Agilent Technologies Inc.: Product Portfolio
• Table 42 : Agilent Technologies Inc.: News/Key Developments, 2023 and 2024
• Table 43 : Bio-Rad Laboratories Inc.: Company Snapshot
• Table 44 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2022 and 2023
• Table 45 : Bio-Rad Laboratories Inc.: Product Portfolio
• Table 46 : Bio-Rad Laboratories Inc.: News/Key Developments, 2023 and 2024
• Table 47 : Bruker: Company Snapshot
• Table 48 : Bruker: Financial Performance, FY 2022 and 2023
• Table 49 : Bruker: Product Portfolio
• Table 50 : Bruker: News/Key Developments, 2023
• Table 51 : Danaher Corp.: Company Snapshot
• Table 52 : Danaher Corp.: Financial Performance, FY 2022 and 2023
• Table 53 : Danaher Corp.: Product Portfolio
• Table 54 : Danaher Corp.: News/Key Developments, 2023 and 2024
• Table 55 : Merck KGaA: Company Snapshot
• Table 56 : Merck KGaA: Financial Performance, FY 2022 and 2023
• Table 57 : Merck KGaA: Product Portfolio
• Table 58 : Merck KGaA: News/Key Developments, 2023
• Table 59 : Shimadzu Corp.: Company Snapshot
• Table 60 : Shimadzu Corp.: Financial Performance, FY 2021 and 2022
• Table 61 : Shimadzu Corp.: Product Portfolio
• Table 62 : Shimadzu Corp.: News/Key Developments, 2023
• Table 63 : Thermo Fisher Scientific Inc.: Company Snapshot
• Table 64 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
• Table 65 : Thermo Fisher Scientific Inc.: Product Portfolio
• Table 66 : Thermo Fisher Scientific Inc.: News/Key Developments, 2023
• Table 67 : Waters Corp.: Company Snapshot
• Table 68 : Waters Corp.: Financial Performance, FY 2022 and 2023
• Table 69 : Waters Corp.: Product Portfolio
• Table 70 : Waters Corp.: News/Key Developments, 2023

List of Figures

• Summary Figure : Global Market for Metabolomics Technologies, by Product, 2024-2029
• Figure 1 : Publications Referencing Metabolomics, 2021-2023
• Figure 2 : Different Metabolomics Techniques
• Figure 3 : Schematic Diagram of Mass Spectrometry
• Figure 4 : Market Dynamics of Global Metabolomics Technologies
• Figure 5 : Global Healthcare Expenditure, 2021-2023
• Figure 6 : Global Shares of Metabolomics Clinical Trials, by Study, 2024
• Figure 7 : Global Shares of Metabolomics Clinical Trials, by Status, 2024
• Figure 8 : Global Shares of Metabolomics Clinical Trials, by Gender, 2024
• Figure 9 : Global Metabolomics Clinical Trials, by Interventions, 2024
• Figure 10 : Selected Granted Patents Involving Metabolomics, by Applicant, 2022 and 2023
• Figure 11 : Global Market Shares of Metabolomics Technologies, by Product, 2023
• Figure 12 : Global Market Shares of Metabolomics Technologies, by Disease Indication, 2023
• Figure 13 : Global Market Shares of Metabolomics Technologies, by Application, 2023
• Figure 14 : Global Market Shares of Metabolomics Technologies, by Region, 2023
• Figure 15 : North American Market Shares of Metabolomics Technologies, by Country, 2023
• Figure 16 : European Market Shares of Metabolomics Technologies, by Country, 2023
• Figure 17 : Asia-Pacific Market Shares of Metabolomics Technologies, by Country, 2023
• Figure 18 : Global Market Shares of Metabolomics Technologies, by Company, 2023
• Figure 19 : Agilent Technologies Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 20 : Agilent Technologies Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 21 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 22 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 23 : Bruker: Revenue Shares, by Business Unit, FY 2023
• Figure 24 : Bruker: Revenue Shares, by Country/Region, FY 2023
• Figure 25 : Danaher Corp.: Revenue Shares, by Business Unit, FY 2023
• Figure 26 : Danaher Corp.: Revenue Shares, by Country/Region, FY 2023
• Figure 27 : Merck KGaA: Revenue Shares, by Business Unit, FY 2023
• Figure 28 : Merck KGaA: Revenue Shares, by Country/Region, FY 2023
• Figure 29 : Shimadzu Corp.: Revenue Shares, by Business Unit, FY 2022
• Figure 30 : Shimadzu Corp.: Revenue Shares, by Country/Region, FY 2022
• Figure 31 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
• Figure 32 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
• Figure 33 : Waters Corp.: Revenue Shares, by Business Unit, FY 2023
• Figure 34 : Waters Corp.: Revenue Shares, by Country/Region, FY 2023

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

The global market for separation techniques for metabolomics technologies is expected to grow from $8.3 billion in 2024 and is projected to reach $15.4 billion by the end of 2029, at a CAGR of 13.1% during the forecast period of 2024 to 2029.

The global market for detection techniques for metabolomics technologies is expected to grow from $8.0 billion in 2024 and is projected to reach $14.8 billion by the end of 2029, at a CAGR of 13.0% during the forecast period of 2024 to 2029.

Report Scope

This report is a comprehensive study of the global metabolomics technologies market. Current and historical market revenues are estimated based on product, indication, application and region.

Report Includes

• 32 data tables and 39 additional tables
• An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms
• Analysis of global market trends, featuring revenue data for 2021-2023, estimates for 2024, forecasts for 2029 and projected CAGRs through 2029
• Evaluation of the current market's size and revenue growth prospects, along with a market share analysis by product, indication, application, and region
• Analysis of the market drivers, restraints and opportunities, and identification of the companies best positioned to meet the demand for metabolics
• A look at ESG trends
• Information on developments in R&D, clinical trials, emerging technologies, and economic trends
• Analysis of key companies' market shares, proprietary technologies, patents, and alliances
• Profiles of the leading companies, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker, Danaher Corp., and Merck KGaA

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview
• Overview of Metabolomics
• Separation Techniques
• Detection Techniques
• Metabolites and Their Applications
• R&D and Regulatory Approval
• Supply Chain Analysis

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Technological Advancements
• Increasing Healthcare Expenditure
• Expanding Applications Across Industries
• Market Restraints
• High Cost of Instruments and Services
• Complexity of Data Analysis
• Standardization and Quality Control Challenges
• Limited Biomarker Validation and Clinical Utility
• Market Opportunities
• Precision Medicine and Personalized Healthcare
• Drug Discovery and Development
• Biomarker Discovery and Validation
• Nutritional Profiling and Functional Foods
• Environmental Monitoring and Toxicology
• Market Challenges
• Data Complexity and Interpretation
• Standardization and Quality Assurance
• Biomarker Validation and Clinical Translation
• Technological Limitations and Costs
• Regulatory and Ethical Considerations

Chapter 4 Emerging Technologies and Developments

• Introduction
• Clinical Trial Analysis
• By Study Type
• By Status
• By Gender
• By Interventions
• Granted Patents
• Introduction
• Patent Analysis

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Metabolomics Market, by Product
• Global Market Analysis and Forecast
• Separation Techniques
• Detection Techniques
• Metabolomics Market, by Indication
• Global Market Analysis and Forecast
• Cancer
• Cardiovascular Disorders
• Neurological Disorders
• Inborn Errors of Metabolism
• Other Diseases Indication
• Metabolomics Market, by Application
• Global Market Analysis and Forecast
• Biomarker Discovery
• Drug Discovery
• Toxicology Testing
• Nutrigenomics
• Functional Genomics
• Others
• Geographic Breakdown
• Metabolomics Market, by Region
• Global
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Company Share Analysis
• Strategic Analysis
• Mergers and Acquisitions
• Venture Capital Funding

Chapter 7 Appendix

• Methodology
• Sources
• Acronyms
• Definitions/Taxonomy
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• BRUKER
• DANAHER CORP.
• MERCK KGAA
• SHIMADZU CORP.
• THERMO FISHER SCIENTIFIC INC.
• WATERS CORP.